Heda Ventures
Overview
HEDA Ventures backs early-stage companies building breakthroughs in biotech, healthcare and TMT industries . Leveraging our global network and local expertise, HEDA Ventures help entrepreneurs to achieve their business expansion by supporting global market opportunities . HEDA Ventures is an early stage venture capital firm focused on accelerating disruptive innovations and trends in Enterprise sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Citcon | Apr 2019 | Series B | - |
| Paragon Genomics | Sep 2017 | Series A | Co-investor |
| Immunowake | May 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Heda Ventures based?
Heda Ventures is headquartered in San Jose, California, United States.
When was Heda Ventures founded?
Heda Ventures was founded in 2008.
How many portfolio companies does Heda Ventures have?
Heda Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in Heda Ventures's portfolio?
Portfolio companies visible on Caplight include Citcon, Paragon Genomics, Immunowake.
What was Heda Ventures's most recent investment shown here?
Heda Ventures's most recent investment in this portfolio sample was in Immunowake in 2022.
What sectors does Heda Ventures focus on?
Heda Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Enterprise Software.
What company stages does Heda Ventures focus on?
Heda Ventures typically invests at the Early stage.
What is Heda Ventures's AUM?
Heda Ventures's assets under management are estimated between $100.0M and $250.0M.